(Q34419628)

2 August 2017

1 reference

title

Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance? (English)

1 reference

2 August 2017

1 reference

Streptococcus pneumoniae

1 reference

Bauer T

1

1 reference

2 August 2017

Ewig S

2

1 reference

2 August 2017

Marcos MA

3

1 reference

2 August 2017

Schultze-Werninghaus G

4

1 reference

2 August 2017

Torres A

5

1 reference

2 August 2017

publication date

1 November 2001

1 reference

Medical Clinics of North America

2 August 2017

published in

1 reference

2 August 2017

volume

85

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

1367-1379

1 reference

A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1997 and October 1997 to January 1998.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Epidemiological Features of and Risk Factors for Infection by Streptococcus pneumoniae Strains with Diminished Susceptibility to Penicillin: Findings of a French Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Penicillin dosing for pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

The drug-resistant pneumococcus: clinical relevance, therapy, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Pneumococcal serotypes and their clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Association of penicillin-resistant pneumococci with residence in a pediatric chronic care facility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992-1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970385-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70385-0

1 reference

2 August 2017

1 reference